SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023243
Filing Date
2020-05-08
Accepted
2020-05-08 07:51:35
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20200331.htm 10-Q 2405456
2 EX-10.1 spro-ex101_166.htm EX-10.1 93276
3 EX-31.1 spro-ex311_6.htm EX-31.1 22399
4 EX-31.2 spro-ex312_8.htm EX-31.2 22316
5 EX-32.1 spro-ex321_7.htm EX-32.1 9826
6 EX-32.2 spro-ex322_9.htm EX-32.2 9829
  Complete submission text file 0001564590-20-023243.txt   8456643

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT spro-20200331.xml EX-101.INS 1701879
8 XBRL TAXONOMY EXTENSION SCHEMA spro-20200331.xsd EX-101.SCH 74363
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20200331_cal.xml EX-101.CAL 52480
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20200331_def.xml EX-101.DEF 226297
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20200331_lab.xml EX-101.LAB 529303
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20200331_pre.xml EX-101.PRE 387506
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 20858703
SIC: 2834 Pharmaceutical Preparations